DK0593639T3 - Pyrrolidin- og thiazolidinderivater, fremstilling af disse forbindelser og lægemidler indeholdende disse - Google Patents
Pyrrolidin- og thiazolidinderivater, fremstilling af disse forbindelser og lægemidler indeholdende disseInfo
- Publication number
- DK0593639T3 DK0593639T3 DK92915456.5T DK92915456T DK0593639T3 DK 0593639 T3 DK0593639 T3 DK 0593639T3 DK 92915456 T DK92915456 T DK 92915456T DK 0593639 T3 DK0593639 T3 DK 0593639T3
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- preparation
- pyrrolidine
- drugs containing
- thiazolidine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9108675A FR2678938B1 (fr) | 1991-07-10 | 1991-07-10 | Derives de pyrrolidine, leur preparation et les medicaments les contenant. |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0593639T3 true DK0593639T3 (da) | 1995-07-03 |
Family
ID=9414933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92915456.5T DK0593639T3 (da) | 1991-07-10 | 1992-07-03 | Pyrrolidin- og thiazolidinderivater, fremstilling af disse forbindelser og lægemidler indeholdende disse |
Country Status (23)
Country | Link |
---|---|
US (1) | US5610144A (no) |
EP (2) | EP0593639B1 (no) |
JP (1) | JP3034043B2 (no) |
KR (1) | KR100234927B1 (no) |
AT (1) | ATE120732T1 (no) |
AU (1) | AU662345B2 (no) |
BR (1) | BR1100717A (no) |
CA (1) | CA2102697C (no) |
CZ (1) | CZ283602B6 (no) |
DE (1) | DE69201956T2 (no) |
DK (1) | DK0593639T3 (no) |
ES (1) | ES2071510T3 (no) |
FI (1) | FI105190B (no) |
FR (1) | FR2678938B1 (no) |
HU (1) | HU223470B1 (no) |
IE (1) | IE66331B1 (no) |
NO (1) | NO180166C (no) |
NZ (1) | NZ243514A (no) |
PL (5) | PL171333B1 (no) |
RU (1) | RU2118316C1 (no) |
SK (1) | SK1694A3 (no) |
WO (1) | WO1993001167A1 (no) |
ZA (1) | ZA925128B (no) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2695641B1 (fr) * | 1992-09-11 | 1994-11-25 | Rhone Poulenc Rorer Sa | (Amino-3 phényl)-1 éthanesulfonate d'hydroquinine optiquement actif, sa préparation et son utilisation. |
FR2700166B1 (fr) * | 1993-01-07 | 1995-02-17 | Rhone Poulenc Rorer Sa | Dérivés de pyrrolidine, leur préparation et les médicaments les contenant. |
FR2700168B1 (fr) * | 1993-01-07 | 1995-02-03 | Rhone Poulenc Rorer Sa | Dérivés de thiazolidine, leur préparation et les médicaments les contenant. |
FR2700167B1 (fr) * | 1993-01-07 | 1995-02-03 | Rhone Poulenc Rorer Sa | Dérivés de pyrrolidine et thiazolidine, leur préparation et les médicaments les contenant. |
FR2700165B1 (fr) * | 1993-01-07 | 1995-02-17 | Rhone Poulenc Rorer Sa | Dérivés de pyrrolidine, leur préparation et les médicaments les contenant. |
US5744485A (en) * | 1994-03-25 | 1998-04-28 | Vertex Pharmaceuticals Incorporated | Carbamates and ureas as modifiers of multi-drug resistance |
FR2721314B1 (fr) * | 1994-06-20 | 1996-07-19 | Rhone Poulenc Rorer Sa | Dérivés de pyrrolidine, leur préparation et les médicaments les contenant. |
FR2721608B1 (fr) * | 1994-06-22 | 1996-07-19 | Rhone Poulenc Rorer Sa | Dérivés de thiazolidine, leur préparation et les médicaments les contenant. |
FR2734724B1 (fr) * | 1995-06-01 | 1997-07-04 | Rhone Poulenc Rorer Sa | Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'alcoolisme |
KR100241643B1 (ko) * | 1995-06-06 | 2000-03-02 | 디. 제이. 우드 | 당뇨병치료제인 치환된 N-(인돌-2-카르보닐)-β-알라님아미드 및 그의 유도체 |
WO1996039385A1 (en) | 1995-06-06 | 1996-12-12 | Pfizer Inc. | Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors |
FR2744361B1 (fr) * | 1996-02-07 | 1998-02-27 | Rhone Poulenc Rorer Sa | Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif |
TW442449B (en) | 1996-07-04 | 2001-06-23 | Hoechst Ag | Process for preparing 1,2-dichloroethane by direct chlorination |
IT1300055B1 (it) * | 1998-04-17 | 2000-04-05 | Boehringer Ingelheim Italia | Eterocicli con anello a 5 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmici |
AU2001268607A1 (en) | 2000-06-21 | 2002-01-02 | Bristol-Myers Squibb Company | Piperidine amides as modulators of chemokine receptor activity |
US6277877B1 (en) * | 2000-08-15 | 2001-08-21 | Pfizer, Inc. | Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors |
HU230376B1 (hu) * | 2000-10-30 | 2016-03-29 | Janssen Pharmaceutica N.V | Tripeptidil peptidáz inhibitorok |
US7105556B2 (en) | 2001-05-30 | 2006-09-12 | Bristol-Myers Squibb Company | Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method |
US7262207B2 (en) | 2002-09-19 | 2007-08-28 | Abbott Laboratories | Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
ATE368647T1 (de) * | 2002-09-19 | 2007-08-15 | Abbott Lab | Pharmazeutische zusammensetzung und ihre verwendung als inhibitoren von der dipeptidyl peptidase iv (dpp-iv) |
US7238724B2 (en) | 2002-09-19 | 2007-07-03 | Abbott Laboratories | Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
US6846836B2 (en) * | 2003-04-18 | 2005-01-25 | Bristol-Myers Squibb Company | N-substituted phenylurea inhibitors of mitochondrial F1F0 ATP hydrolase |
US7230002B2 (en) | 2004-02-03 | 2007-06-12 | Glenmark Pharmaceuticals Ltd. | Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof |
BRPI0507612A (pt) * | 2004-02-11 | 2007-07-03 | Univ Ohio State Res Found | análogos exibindo inibição de proliferação de célula e métodos para fabricação e uso destes |
WO2007086584A1 (ja) * | 2006-01-30 | 2007-08-02 | Meiji Seika Kaisha, Ltd. | 新規FabKおよびFabI/K阻害剤 |
EP2057145B1 (en) * | 2006-07-20 | 2012-08-22 | Abbott Laboratories | Synthesis of (2s,5r)-5-ethynyl-1-{n-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile |
US8247438B2 (en) * | 2008-02-27 | 2012-08-21 | Neuropill, Inc. | Methods for treating schizophrenia |
CN101407502B (zh) * | 2008-11-21 | 2010-12-22 | 南京大学 | 一类n-(叔丁氧基羰基)噻唑烷酸类化合物及其制法和用途 |
DE102009004204A1 (de) * | 2009-01-09 | 2010-07-15 | Christian-Albrechts-Universität Zu Kiel | Verfahren zur verbesserten Bioaktivierung von Arzneistoffen |
BR112012018374B1 (pt) * | 2009-12-18 | 2021-09-21 | Epics Therapeutics | Derivados de ácido carboxílico de pirrolidina ou tiazolidina para distúrbios metabólicos como agonistas de receptor 43 acoplado à proteína g (gpr43), seu processo de preparação e composição farmacêutica |
WO2012036962A2 (en) | 2010-09-13 | 2012-03-22 | Amylin Pharmaceuticals, Inc. | C-terminal amidation of polypeptides |
JP6854126B2 (ja) | 2013-11-27 | 2021-04-07 | エピックス セラピューティクス | 炎症性疾患の治療に使用するための化合物、医薬組成物、および方法 |
EP3248013B1 (en) | 2015-01-24 | 2020-07-15 | Academia Sinica | Cancer markers and methods of use thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH362072A (de) * | 1957-03-19 | 1962-05-31 | Ciba Geigy | Verfahren zur Herstellung neuer Acylpiperidine |
US4499102A (en) * | 1979-12-13 | 1985-02-12 | Santen Pharmaceutical Co., Ltd. | Thiazolidine and pyrrolidine compounds and pharmaceutical compositions containing them |
EP0059966B1 (en) * | 1981-03-09 | 1986-08-13 | Merck & Co. Inc. | Substituted thiazolidine carboxylic acid analogs and derivatives as antihypertensives |
DE3332633A1 (de) * | 1983-09-09 | 1985-04-04 | Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München | Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel |
CA2022346A1 (en) * | 1989-08-04 | 1991-02-05 | Mitsubishi Chemical Corporation | 1-phenylalkyl-3-phenylurea derivatives |
US5258405A (en) * | 1990-03-12 | 1993-11-02 | Yamanouchi Pharmaceutical Co., Ltd. | Urea derivatives and salts thereof in method for inhibiting the ACAT enzyme |
-
1991
- 1991-07-10 FR FR9108675A patent/FR2678938B1/fr not_active Expired - Fee Related
-
1992
- 1992-07-03 HU HU9400061A patent/HU223470B1/hu active IP Right Grant
- 1992-07-03 CA CA002102697A patent/CA2102697C/fr not_active Expired - Lifetime
- 1992-07-03 WO PCT/FR1992/000626 patent/WO1993001167A1/fr active IP Right Grant
- 1992-07-03 AT AT92915456T patent/ATE120732T1/de active
- 1992-07-03 PL PL92302029A patent/PL171333B1/pl unknown
- 1992-07-03 PL PL92313379A patent/PL171094B1/pl unknown
- 1992-07-03 DK DK92915456.5T patent/DK0593639T3/da active
- 1992-07-03 DE DE69201956T patent/DE69201956T2/de not_active Expired - Lifetime
- 1992-07-03 CZ CZ9449A patent/CZ283602B6/cs not_active IP Right Cessation
- 1992-07-03 KR KR1019940700052A patent/KR100234927B1/ko not_active IP Right Cessation
- 1992-07-03 US US08/175,381 patent/US5610144A/en not_active Expired - Lifetime
- 1992-07-03 EP EP92915456A patent/EP0593639B1/fr not_active Expired - Lifetime
- 1992-07-03 PL PL92313380A patent/PL171054B1/pl unknown
- 1992-07-03 SK SK16-94A patent/SK1694A3/sk unknown
- 1992-07-03 JP JP5502018A patent/JP3034043B2/ja not_active Expired - Lifetime
- 1992-07-03 PL PL92313381A patent/PL171112B1/pl unknown
- 1992-07-03 ES ES92915456T patent/ES2071510T3/es not_active Expired - Lifetime
- 1992-07-03 AU AU23275/92A patent/AU662345B2/en not_active Expired
- 1992-07-03 EP EP92401904A patent/EP0527069A1/fr active Pending
- 1992-07-03 PL PL92313382A patent/PL171095B1/pl unknown
- 1992-07-09 ZA ZA925128A patent/ZA925128B/xx unknown
- 1992-07-09 IE IE922244A patent/IE66331B1/en not_active IP Right Cessation
- 1992-07-10 NZ NZ243514A patent/NZ243514A/en not_active IP Right Cessation
-
1993
- 1993-01-21 RU RU94015258/04A patent/RU2118316C1/ru active
- 1993-11-26 NO NO934300A patent/NO180166C/no not_active IP Right Cessation
-
1994
- 1994-01-07 FI FI940072A patent/FI105190B/fi not_active IP Right Cessation
-
1997
- 1997-05-04 BR BR1100717-6A patent/BR1100717A/pt active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0593639T3 (da) | Pyrrolidin- og thiazolidinderivater, fremstilling af disse forbindelser og lægemidler indeholdende disse | |
NO921835L (no) | Fremgangsmaate for fremstilling av amidinofenylalaninderivat samt anvendelse derav | |
ATE84413T1 (de) | Arzneimittel, enthaltend di-tert.butylhydroxyphenyl-derivatesowie neue derivate. | |
DK0530087T3 (da) | Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
DK163287D0 (da) | 1,4-diazepiner og farmaceutiske midler med indhold af saadanne forbindelser | |
DK324185D0 (da) | 2-substituerede 1,3-propylidendiphosphonatderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf | |
NO930029L (no) | 4,13-dioxabicyklo(8.2.1)tridecenonderivater, fremgangsmaater og mellomprodukter for deres fremstilling, og legemidler inneholdene disse forbindelser | |
ES2091310T3 (es) | Nuevos derivados de la n-benzoil-prolina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
ES2111871T3 (es) | Nuevos derivados de aminoacidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
DK162682A (da) | Oxindolderivater,deres fremstilling og anvendelse | |
DK284588A (da) | Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler. | |
ES2098517T3 (es) | Derivados de 1,2,4-tiadiazino(3,4-b)benzotiazol, su preparacion y los medicamentos que los contienen. | |
DK592988A (da) | Laegemiddel, deri indeholdende phosphorholdige 2-isoxazoliner og isoxazoler, samt fremstilling af disse heterocycliske forbindelser | |
DK0481288T3 (da) | N-phenylpiperidyl-4-aminer og lægemidler indeholdende disse forbindelser | |
DK0450588T3 (da) | Substituerede 3-thia- og 3-oxa-alkyl-flavoner, fremgangsmåder til deres fremstilling, deres anvendelse, lægemidler på grundlag af disse forbindelser samt mellemprodukter | |
ES2032573T3 (es) | Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona. | |
DK0478941T3 (da) | Lægemidler indeholdende substituerede 2-cyclohexen-1-yl-amin-derivater og deres anvendelse til bekæmpelse af sygdomme | |
DK672289A (da) | Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemidler indeholdende disse |